Related Experiment Video
Updated: Dec 10, 2025

Characterizing Extracellular Vesicles from Biological Fluids
Published on: February 28, 2025
Extracellular Vesicles in Essential Hypertension: Hidden Messengers
Sabrina La Salvia1, Pradeep Moon Gunasekaran2, James Brian Byrd2
1Department of Internal Medicine, Division of Nephrology, University of Virginia Health System, 1300 Jefferson Park Avenue, Charlottesville, VA, 22908-0133, USA. sabrina.lasalvia01@universitadipavia.it.
Extracellular vesicles (EVs) show promise as biomarkers and bioactivators for hypertension (HTN). Further research with advanced tools is needed to understand their role in HTN pathophysiology and potential therapeutic applications.
Area of Science:
- Biomedical research
- Molecular biology
- Cardiovascular science
Background:
- Hypertension (HTN) affects nearly half of Americans, with unclear causative factors in most cases.
- Understanding the molecular basis of HTN and its phenotypes is a critical research priority.
- Extracellular vesicles (EVs), shed from cells into body fluids, carry molecular cargo and mediate cell-to-cell communication.
Purpose of the Study:
- To review the diagnostic, functional, and regenerative roles of EVs in essential hypertension.
- To focus on the protein and RNA content within EVs as key areas of study.
- To highlight the emerging potential of EVs as biomarkers and therapeutic agents in HTN.
Main Methods:
- Review of current scientific literature on extracellular vesicles and hypertension.
- Analysis of studies focusing on EV protein and RNA cargo.
- Discussion of novel EV detection tools and research methodologies.
Main Results:
- EVs are emerging as potential biomarkers for HTN, correlating with disease severity and potential end-organ damage.
- Specific EV subtypes that best reflect HTN pathophysiology require further identification.
- EVs demonstrate potential roles in regulating vascular and renal tubular function, with therapeutic possibilities.
Conclusions:
- Extracellular vesicles (EVs) are promising novel biomarkers and bioactivators for essential hypertension.
- Increased rigor and transparency in EV research are necessary, utilizing advanced tools and models.
- Further investigation into EV subtypes, cargo, and in vivo/human studies is crucial for clinical translation.
Related Concept Videos
Hormonal Regulation of Blood Pressure
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Hypertension II: Pathophysiology
Overview of Secretory Vesicles
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Hypertension and Regulation of Blood Pressure

